FDA-2024-0001-V001

Minor variation for application FDA-2024-0001. Minor variation: Specification Change for Kcluximab — minor update

Variation Number
FDA-2024-0001-V001
Type
Minor
Application
FDA-2024-0001
Change
CHG-2024-0001
Status
Overdue
Fee
€1,982
Submitted
2024-04-28
Approved
—
Description

Minor variation: Specification Change for Kcluximab — minor update